Ray Therapeutics Tackles a Rare Blinding Disease With $100 Million in Financing
Wall Street Journal
Gene therapies may help a wider group of patients with retinitis pigmentosa, a vision disorder that leads to blindness. Ray Therapeutics is looking to treat people who’ve lost their sight, while other startups are aiming at earlier stages.